ELP-dependent expression of MCL1 promotes resistance to EGFR inhibition in triple-negative breast cancer cells
P. Cruz-Gordillo, M. E. Honeywell, T. Leete, M. J. Lee
The study identifies the ELP complex as a mediator of resistance to EGFR inhibition in TNBC by promoting MCL1 expression, suggesting co-targeting EGFR and MCL1 as a therapeutic strategy.
bioRxiv · Mar 29, 2020Cancer Biology